ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 256.6 | 191.3 | 179.9 |
| Other income | 5.7 | 6.7 | 1.2 |
| Total income | 262.4 | 198.1 | 181.1 |
| Profit before exceptional items & tax | 24.8 | 17.5 | 0.6 |
| Exceptional items | 33.4 | -25.0 | 0.0 |
| Profit before tax | -8.6 | 42.5 | 0.6 |
| Net profit | -9.6 | 43.4 | 0.7 |
| Operating margin | -3.3% | 21.5% | 0.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +42.60% |
|---|---|
| Operating profit, year on year | +3283.30% |
| Operating profit, quarter on quarter | +76.90% |
BSE results filing, NSE: CAPILLARY. Figures extracted from the filing.
Capillary Technologies India Ltd: key numbers
- Share price
- ₹510.00
- Market cap
- ₹4,064 Cr
- Revenue (annual)
- ₹734.6 Cr
- Net profit (annual)
- ₹52.39 Cr
- P/E (TTM)
- 63.8×Sector 23.6×
- Promoter holding
- 47.23%-4.22% QoQ
- FII holding
- 2.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Capillary Technologies India Ltd
All →Capillary Technologies India Earnings Call Transcript: Key Takeaways
Q2 revenue ₹271 Cr (+51% YoY, +43% constant currency), adjusted EBITDA ₹44.8 Cr at 17% margin. Organic H1 growth is 23%; inorganic (Session M) doubled and drove the headline.
- Call
- Guides 20% growth
Capillary Technologies India Employee Stock Options
Capillary Technologies allotted 94,553 equity shares of ₹2 each upon exercise of vested ESOP 2021 options. The allotment was approved by circular resolution on November 04, 2026.
Capillary Technologies India Business Update
Capillary Technologies announced the strategic shutdown of its China operations due to low growth. Both quantitative and qualitative effects of the restructuring are stated as nil.
Capillary Technologies India Management Change
Capillary Technologies replaced internal auditor Protiviti with Deloitte Touche Tohmatsu India LLP on a 15-month term. The board cited expanding international operations as the reason.
Capillary Technologies India Other Announcement
Capillary Technologies appointed Deloitte Touche Tohmatsu India LLP as Internal Auditor, replacing Protiviti India. The change takes effect November 02, 2026.
Capillary Technologies India Results Update
Capillary announced Q2 FY27 revenue of ₹2,713.5 Mn (+51% YoY) and Adjusted EBITDA of ₹448.6 Mn (+103%). H1 FY27 revenue grew 47% with EBITDA up 116%.